18 minutes agoPfizer's vaccine is granted emergency use license in Great Britain
Periskopi(6 years ago)
(6 years ago)Great Britain has become the first Western state to give license to use a vaccine against Coronavirus, paving the way for massive population immunization with the vaccine developed by the American company, “Pfizer”, in collaboration with the German company, “BioNTech”, for persons most at risk. This vaccine [...]
This vaccine was approved for urgent use by the Regulatory Authority for Medical Products, and the decision was made earlier than decisions expected to be made later in the United States and the European Union.
This body was granted competencies for providing government approval under separate regulations before January 1st next year, when authority will be fully responsible for authorisations of medical products in Britain after BRUXT.
The company “Pfixer” said the first doses will reach the UK in the coming days. Great Britain has purchased 40 million doses of vaccines in question, which in testing has shown 95 percent efficiency, writes The Guardian, broadcast the Express.
Today's autoriism for emergency use in Britain marks a milestone in the fight against COVID-19. This authorization is a goal for which we have worked hard from the day when we first declared that science will win”, said Albert Bourla, chief executive of the company “Pfixer”.
Although vaccines must be preserved in particular conditions, at temperatures - 70 degrees Fahrenheit [2 - 70 ° C], companies that have developed it have said that it can be kept for up to five days in ordinary refrigerators, at temperatures of between 2 and 8 degrees.
According to the results of testing people, this vaccine is both effective in young people and those over 65, who are mostly endangered by coronarys. Vaxin has done the same for members of gender, race, and ethnicity.
